GB0600928D0 - Improvements relating to lantibiotics - Google Patents

Improvements relating to lantibiotics

Info

Publication number
GB0600928D0
GB0600928D0 GBGB0600928.6A GB0600928A GB0600928D0 GB 0600928 D0 GB0600928 D0 GB 0600928D0 GB 0600928 A GB0600928 A GB 0600928A GB 0600928 D0 GB0600928 D0 GB 0600928D0
Authority
GB
United Kingdom
Prior art keywords
actagardine
lantibiotics
improvements relating
variant
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0600928.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novacta Biosystems Ltd
Original Assignee
Novacta Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacta Biosystems Ltd filed Critical Novacta Biosystems Ltd
Priority to GBGB0600928.6A priority Critical patent/GB0600928D0/en
Publication of GB0600928D0 publication Critical patent/GB0600928D0/en
Priority to EP20100000424 priority patent/EP2189472A1/en
Priority to NZ569486A priority patent/NZ569486A/en
Priority to AU2007206769A priority patent/AU2007206769B2/en
Priority to US12/161,221 priority patent/US7989416B2/en
Priority to CA002637315A priority patent/CA2637315A1/en
Priority to KR1020087018136A priority patent/KR101573536B1/ko
Priority to JP2008550839A priority patent/JP5219837B2/ja
Priority to EP07704921A priority patent/EP1979375B9/en
Priority to SI200730846T priority patent/SI1979375T1/sl
Priority to PCT/GB2007/000138 priority patent/WO2007083112A2/en
Priority to CN2007800067480A priority patent/CN101389641B/zh
Priority to PT07704921T priority patent/PT1979375E/pt
Priority to AT07704921T priority patent/ATE534659T1/de
Priority to BRPI0706525-6A priority patent/BRPI0706525A2/pt
Priority to MX2008009047A priority patent/MX2008009047A/es
Priority to US13/705,010 priority patent/USRE45003E1/en
Priority to DK07704921.1T priority patent/DK1979375T3/da
Priority to ES07704921T priority patent/ES2378090T3/es
Priority to PL07704921T priority patent/PL1979375T3/pl
Priority to IL192446A priority patent/IL192446A0/en
Priority to US13/157,454 priority patent/US8465947B2/en
Priority to CY20121100166T priority patent/CY1112559T1/el
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/365—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinoplanes (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0600928.6A 2006-01-17 2006-01-17 Improvements relating to lantibiotics Ceased GB0600928D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB0600928.6A GB0600928D0 (en) 2006-01-17 2006-01-17 Improvements relating to lantibiotics
PL07704921T PL1979375T3 (pl) 2006-01-17 2007-01-17 Klastry biosyntetycznych genów kodujących lantybiotyki pochodzące od a. garbadinensis oraz a. liguriae
PCT/GB2007/000138 WO2007083112A2 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
PT07704921T PT1979375E (pt) 2006-01-17 2007-01-17 Aglomerados de genes biossintéticos lantibióticos de a. garbadinensis e a. liguriae
AU2007206769A AU2007206769B2 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae
US12/161,221 US7989416B2 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. Liguriae
CA002637315A CA2637315A1 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
KR1020087018136A KR101573536B1 (ko) 2006-01-17 2007-01-17 악티노플레인스 가르바디넨시스 및 악티노플레인스리구리애로부터의 란티바이오틱 생합성 유전자 클러스터
JP2008550839A JP5219837B2 (ja) 2006-01-17 2007-01-17 Ａ．ガルバジネンシスおよびａ．リグリエに由来するランチビオティック生合成遺伝子クラスター
EP07704921A EP1979375B9 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
SI200730846T SI1979375T1 (sl) 2006-01-17 2007-01-17 Lantibiotični biosintetični skupki genov iz A garbadinensis in A liguriae
EP20100000424 EP2189472A1 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae
CN2007800067480A CN101389641B (zh) 2006-01-17 2007-01-17 来自菌株产加尔巴丁游动放线菌和利古里亚游动放线菌中的羊毛硫细菌素的生物合成成簇基因
NZ569486A NZ569486A (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from A.garbadinensis and A.liguriae
AT07704921T ATE534659T1 (de) 2006-01-17 2007-01-17 Biosynthetische gencluster für lantibiotikum aus a. garbadinensis und a. liguriae
BRPI0706525-6A BRPI0706525A2 (pt) 2006-01-17 2007-01-17 grupamentos genéticos biossintéticos de lantiobióticos de a. garbadinensis e a. liguriae
MX2008009047A MX2008009047A (es) 2006-01-17 2007-01-17 Grupos de genes biosinteticos lantibioticos de a. garbadinesis y a. liguriae.
US13/705,010 USRE45003E1 (en) 2006-01-17 2007-01-17 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae
DK07704921.1T DK1979375T3 (da) 2006-01-17 2007-01-17 Lantibiotiske, biosyntetiske genklynger fra A. garbadinensis og A. liguriae
ES07704921T ES2378090T3 (es) 2006-01-17 2007-01-17 Clústeres de genes biosintéticos lantibióticos a partir de A. garbadinensis y A. liguriae
IL192446A IL192446A0 (en) 2006-01-17 2008-06-25 Lantibiotic biosynthetic gene clusters form a. garbadinensis and a. liguriae
US13/157,454 US8465947B2 (en) 2006-01-17 2011-06-10 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae
CY20121100166T CY1112559T1 (el) 2006-01-17 2012-02-17 Βιοσυνθετικα συναθροισματα γονιδιων λαντιβιοτικων απο α. garbadinensis και α. liguriae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0600928.6A GB0600928D0 (en) 2006-01-17 2006-01-17 Improvements relating to lantibiotics

Publications (1)

Publication Number Publication Date
GB0600928D0 true GB0600928D0 (en) 2006-02-22

Family

ID=35998187

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0600928.6A Ceased GB0600928D0 (en) 2006-01-17 2006-01-17 Improvements relating to lantibiotics

Country Status (20)

Country Link
US (3) US7989416B2 (https=)
EP (2) EP2189472A1 (https=)
JP (1) JP5219837B2 (https=)
KR (1) KR101573536B1 (https=)
CN (1) CN101389641B (https=)
AT (1) ATE534659T1 (https=)
AU (1) AU2007206769B2 (https=)
BR (1) BRPI0706525A2 (https=)
CA (1) CA2637315A1 (https=)
CY (1) CY1112559T1 (https=)
DK (1) DK1979375T3 (https=)
ES (1) ES2378090T3 (https=)
GB (1) GB0600928D0 (https=)
IL (1) IL192446A0 (https=)
MX (1) MX2008009047A (https=)
NZ (1) NZ569486A (https=)
PL (1) PL1979375T3 (https=)
PT (1) PT1979375E (https=)
SI (1) SI1979375T1 (https=)
WO (1) WO2007083112A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0900599D0 (en) 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
SI2387580T1 (sl) * 2009-01-14 2014-11-28 Novacta Biosystems Limited Deoksiaktagardinski derivati
MX2011008043A (es) * 2009-02-04 2011-08-17 Novacta Biosystems Ltd Derivados de actagardina.
JP5852966B2 (ja) * 2010-02-02 2016-02-03 ノヴァクタ バイオシステムズ リミティッド ランチビオティックの塩
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
US20130171252A1 (en) 2010-07-14 2013-07-04 Novacta Biosystems Limited Formulation Comprising a Type B Lantibiotic
GB201013509D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013508D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013507D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
EP2925342A4 (en) 2012-11-30 2016-07-06 Naicons Srl NOVEL LANTIBIOTIC DERIVATIVES AND PREPARATION METHOD THEREOF
CN103483433B (zh) * 2013-09-10 2015-05-27 中国科学院微生物研究所 一种新型高效的羊毛硫细菌素cerecidin及其应用
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
CN113777306A (zh) * 2020-06-09 2021-12-10 首都医科大学附属北京世纪坛医院 尿液果糖二磷酸醛缩酶b及其多肽片段在烧伤中的应用
CN115637247B (zh) * 2021-07-20 2026-02-24 中国科学院微生物研究所 生物氧化脱硫的盐单胞菌工程菌株及其全细胞催化脱硫方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
GB8507528D0 (en) 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5304540A (en) 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
IN167138B (https=) 1988-08-17 1990-09-01 Hoechst India
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
IT1260505B (it) 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
IL107887A (en) 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US5512269A (en) 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
EP0700998B1 (en) 1994-09-12 2003-11-26 Aventis Pharma Deutschland GmbH Recombinant mersacidin and a method for production
CN1138560C (zh) 1995-06-23 2004-02-18 Ambi股份有限公司 控制对抗生素耐药的革兰氏阳性细菌的方法和治疗感染的方法
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US5958873A (en) 1997-06-09 1999-09-28 University Of Cincinnati Oral formulation for treatment of bacteria-induced diseases of the colon
US5985823A (en) 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
DE19745583A1 (de) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
US6569830B1 (en) 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
ATE273695T1 (de) 2000-06-28 2004-09-15 Smithkline Beecham Plc Nassvermahlung
GB0110432D0 (en) * 2001-04-27 2001-06-20 Plant Bioscience Ltd Lantibiotic production
WO2002103010A1 (en) 2001-06-14 2002-12-27 Plant Bioscience Limited Methods and materials for targeted gene disruption in actinomycete bacteria
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
JP2006502713A (ja) 2002-10-10 2006-01-26 モリケム メディシンズ， インコーポレイテッド デュラマイシンをコードする核酸
ES2281808T3 (es) 2003-07-18 2007-10-01 Vicuron Pharmaceuticals, Inc. Antibiotico 107891, sus factores a1 y a2, composiciones y sales farmaceuticamente aceptables y uso del mismo.
US7351687B2 (en) 2003-07-18 2008-04-01 Vicuron Pharmaceuticals, Inc. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
US20050271650A1 (en) * 2004-02-17 2005-12-08 Cellmatrix, Inc. Method and composition for angiogenesis inhibition
GB0406870D0 (en) 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
JP2009509519A (ja) 2005-09-27 2009-03-12 ノヴァクタ バイオシステムズ リミティッド ランチビオティックメルサシジンの変種およびそれらの使用
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
KR20120038021A (ko) 2006-10-27 2012-04-20 화이자 프로덕츠 인코포레이티드 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
CA2690267A1 (en) 2007-06-12 2008-12-18 The University Of British Columbia Small cationic antimicrobial peptides
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
WO2010058238A1 (en) 2008-11-24 2010-05-27 Sentinella Pharmaceuticals, Inc. ("Sentinella") Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
SI2387580T1 (sl) 2009-01-14 2014-11-28 Novacta Biosystems Limited Deoksiaktagardinski derivati
GB0900599D0 (en) 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
MX2011008043A (es) 2009-02-04 2011-08-17 Novacta Biosystems Ltd Derivados de actagardina.
EP2216937A1 (en) 2009-02-10 2010-08-11 Alcatel Lucent Alarm notification between customer premises equipment and a remote management server

Also Published As

Publication number Publication date
MX2008009047A (es) 2008-12-18
JP5219837B2 (ja) 2013-06-26
AU2007206769B2 (en) 2013-06-20
CN101389641B (zh) 2013-06-05
KR101573536B1 (ko) 2015-12-11
CA2637315A1 (en) 2007-07-26
DK1979375T3 (da) 2012-03-19
WO2007083112A3 (en) 2008-05-08
EP1979375B1 (en) 2011-11-23
US7989416B2 (en) 2011-08-02
USRE45003E1 (en) 2014-07-08
JP2009523777A (ja) 2009-06-25
IL192446A0 (en) 2008-12-29
WO2007083112A2 (en) 2007-07-26
PL1979375T3 (pl) 2012-04-30
AU2007206769A1 (en) 2007-07-26
EP1979375A2 (en) 2008-10-15
US20100048459A1 (en) 2010-02-25
NZ569486A (en) 2011-07-29
EP1979375B9 (en) 2012-05-09
EP2189472A1 (en) 2010-05-26
PT1979375E (pt) 2012-03-06
CN101389641A (zh) 2009-03-18
ES2378090T3 (es) 2012-04-04
CY1112559T1 (el) 2016-02-10
US20110306091A1 (en) 2011-12-15
BRPI0706525A2 (pt) 2011-03-29
US8465947B2 (en) 2013-06-18
KR20080086517A (ko) 2008-09-25
ATE534659T1 (de) 2011-12-15
SI1979375T1 (sl) 2012-03-30

Similar Documents

Publication Publication Date Title
PL1979375T3 (pl) Klastry biosyntetycznych genów kodujących lantybiotyki pochodzące od a. garbadinensis oraz a. liguriae
WO2010075983A8 (en) Process for the production of bivalirudin
ZA200705777B (en) The transcription factor gene osnacx from rice and use for improving tolerance of plants to drought and salt thereof
PL1999160T3 (pl) Akrylowany kwas hialuronowy
IN2012DN01652A (https=)
PL1781697T3 (pl) Nowa karbamylowana EPO i sposób jej wytwarzania
MX2011006334A (es) Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c] [1,2]-oxaborol-1-ol.
NZ598724A (en) Soybean transgenic event mon 87708 and methods of use thereof
TW200722446A (en) Process for the production of melt-processable polyurethanes
UA105785C2 (uk) Спосіб очищення ліпопептидів
PL2333076T3 (pl) Żywność o niskiej zawartości akrylamidu
WO2005065339A3 (en) Cell cycle genes and related methods of using
WO2006138606A3 (en) Cell signaling genes and related methods
WO2008087224A3 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
PT1962578E (pt) Plantas de melão resistentes a closterovirus
WO2008056144A3 (en) Methods for detecting toluene and xylene using as biosensor a tranformed acinetobacter baylyi adp1
IN2012DN05156A (https=)
SI1948689T1 (sl) Visokoaktivni mutanti rastnega faktorja
WO2009054511A1 (ja) 新規なａｔｐ：クエン酸リアーゼ遺伝子
GB0410448D0 (en) Purification methods
MX2009005810A (es) Celulas hospederas optimizadas para la produccion de proteinas.
WO2008117179A3 (en) Polynucleotides and polypeptides of human factor vii gene, snps
MX2008013416A (es) Medios para inhibir la expresion de cd31.
PL1945760T3 (pl) Czynnik białkowy zwiększający produktywność, nowe linie komórek i ich zastosowania
WO2008081922A1 (ja) TRACP5bの製造方法

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)